Efficacy of oral antibiotics on acne vulgaris and their effects on quality of life: A multicenter randomized controlled trial using minocycline, roxithromycin and faropenem

Journal of Dermatology

Volumn 38, Issue 2, 2011, Pages 111-119

  Hayashi, Nobukazu ^a   Kawashima, Makoto ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

acne vulgaris; antibacterial agents; Propionibacterium acnes; quality of life; randomized controlled trial

Indexed keywords

CLINDAMYCIN; FROPENEM; MINOCYCLINE; NADIFLOXACIN; ROXITHROMYCIN;

ABSENCE OF SIDE EFFECTS; ACNE VULGARIS; ADOLESCENT; ADULT; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DRUG EFFECT; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTICENTER STUDY; NAUSEA; NONHUMAN; PROPIONIBACTERIUM ACNES; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SKINDEX 16 SCALE; TREATMENT OUTCOME;

ACNE VULGARIS; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BETA-LACTAMS; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; PATIENT SATISFACTION; PROPIONIBACTERIUM ACNES; QUALITY OF LIFE; ROXITHROMYCIN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79251545512     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2010.00969.x     Document Type: Article

References (12)

1. Hayashi N, Akamatsu H, Iwatsuki K, et al. The Guideline for the treatment of acne vulgaris. Jpn J Dermatol 2008; 118: 1893-1923. (In Japanese.)
2. Hayashi N, Akamatsu H, Kawashima M, Acne Study Group. Establishment of grading criteria for acne severity. J Dermatol 2008; 35: 255-260.
3. Garner SE, Eady A, Popescu CM, Newton J, Li Wan Po A,. Minocycline for acne vulgaris: efficacy and safety. Cochrane Database Syst Rev 2003; (1): CD002086. DOI
4. Ferahbas A, Utas S, Aykol D, Borlu M, Uksal U,. Clinical evaluation of roxithromycin: a double-blind, placebo-controlled and crossover trial in patients with acne vulgaris. J Dermatol 2004; 31: 6-9.
5. Ishida N, Nakaminami H, Noguchi N, Kurokawa I, Nishijima S, Sasatsu M,. Antimicrobial susceptibilities of Propionibacterium acnes isolated from patients with acne vulgaris. Microbiol Immunol 2008; 52: 621-624.
6. Nogita T,. Clinical efficacy of faropenem sodium (FRPM) in the treatment of acne vulgaris with inflammatory lesions. J New Rem & Clin 2008; 57: 511-518. (In Japanese.)
7. Endo H, Wada T, Narita T, et al. Clinical study of faropenem (FRPM) for acne vulgaris with inflammatory lesions: antibacterial activities of various antibacterial agents on Propionibacterium acnes and Staphylococcus epidermidis isolated from patients with acne vulgaris. Antibiot Chemother 2009; 25: 95-102. (In Japanese.)
8. Higaki Y, Kawamoto K, Kamo T, Horikawa N, Kawashima M, Chren MM,. The Japanese version of Skindex-16: a brief quality-of-life measure for patients with skin diseases. J Dermatol 2002; 29: 693-698.
9. Â) in treatment of acne: comparison with minocycline hydrochloride. Nishinihon J Dermatol 2007; 69: 424-427. (In Japanese.)
10. Hayashi N, Higaki Y, Kawamoto K, Kamo T, Shimizu S, Kawashima M,. A cross-sectional analysis of quality of life in Japanese acne patients using the Japanese version of Skindex-16. J Dermatol 2004; 31: 971-976.
11. Ross JI, Snelling AM, Carnegie E, et al. Antibiotic-resistant acne: lessons from Europe. Br J Dermatol 2003; 148: 467-478.
12. Thiboutot D, Gollnick H, Bettoli V, et al. New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group. J Am Acad Dermatol 2009; 60: S1-S50.